Kanuma 2 mg/ml Konzentrat zur Herstellung einer Infusionslösung Suiza - alemán - Swissmedic (Swiss Agency for Therapeutic Products)

kanuma 2 mg/ml konzentrat zur herstellung einer infusionslösung

alexion pharma gmbh - sebelipasum alfa - konzentrat zur herstellung einer infusionslösung - sebelipasum alfa 2 mg, trinatrii citras dihydricus corresp. natrium 3.2 mg, acidum citricum monohydricum, albuminum seri humani, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - langfristige enzymersatztherapie bei patienten aller altersgruppen mit lal-mangel - biotechnologika

HLAL RDNA CONSTRUCT IN SBC LAL-C CHICKENS- hlal rdna construct in sbc lal-c chicken not applicable Estados Unidos - inglés - NLM (National Library of Medicine)

hlal rdna construct in sbc lal-c chickens- hlal rdna construct in sbc lal-c chicken not applicable

alexion pharmaceuticals, inc. - hlal rdna construct in sbc lal-c chicken (unii: mg6au4c2hb) (hlal rdna construct in sbc lal-c chicken - unii:mg6au4c2hb) - hlal rdna construct in sbc lal-c chicken 1 [arb'u] in 1 [arb'u] - the sbc lal-c lineage must be housed in only those alexion pharmaceutical, inc. facilities specified in the approved application.

SOLIRIS Solution Canadá - francés - Health Canada

soliris solution

alexion pharma gmbh - Éculizumab - solution - 10mg - Éculizumab 10mg - complement inhibitors

STRENSIQ Solution Canadá - francés - Health Canada

strensiq solution

alexion pharma gmbh - asfotase alfa - solution - 40mg - asfotase alfa 40mg - enzymes

STRENSIQ Solution Canadá - francés - Health Canada

strensiq solution

alexion pharma gmbh - asfotase alfa - solution - 40mg - asfotase alfa 40mg - enzymes

STRENSIQ Solution Canadá - francés - Health Canada

strensiq solution

alexion pharma gmbh - asfotase alfa - solution - 40mg - asfotase alfa 40mg - enzymes